Focal laser ablation (FLA) presents a promising, minimally invasive alternative for treating low-to-intermediate risk prostate cancer, while maintaining quality of life. The CLS TRANBERG™ Thermal Therapy System for FLA of soft tissue, such as the prostate gland, is FDA 510(k) Cleared* and commercially available in the US via CLS Americas Inc.
The system offers multiple options to control ablation by treatment power and time, as well as real time tissue temperature measurements.
*The TRANBERG™ Thermal Therapy System is also CE-marked.
CLS Americas offers its TRANBERG™ System for focal laser ablation, and accessories, via a Mobile Services Provider (MSP) program.
Product training before the first treatment is of course also included.
Benefits of the Practice:
Learn how you can easily incorporate this new focal laser treatment into your practice without adding any capital equipment expense by listening to the presentations available below.
Want to learn more about the CLS MSP Program and our commercially available products?
Fill out the contact form and get in touch with a member of our team.
Welcome to Clinical Laserthermia Systems.
Please note that all our products and indications are not yet approved in all markets. Don’t hesitate to contact us for up-to-date market approvals in your area!
Please choose your country or region
Clinical Laserthermia Systems Americas Inc.
3 Park Plaza, Suite 1700
Irvine, CA 92614 USA
Phone: +1 (949) 504-5440
E-mail: contact-us@clinicallaser.com
©Copyright 2024 CLS AB. All rights reserved.
MM-2022-026-US/Rev3